Pages
- About ACTA
- Privacy
- Sitemap
- Early phase decision making in the pharmaceutical industry
- Adaptive Multi-Arm Platform Trials: Benefits and Efficiencies
- A practical guide to investigator-led platform trials in Australia
- Three Bayesian trials with adaptive sample size and response-adaptive randomisation
- REMAP-CAP: A multi-factoral, multi-intervention, multi-strata Bayesian adaptive trial
- Novel trial design in oncology
- Adaptive randomised control trials (RCTs) in stroke
- An overview of adaptive trial designs
- News
- Activities
- Resources Hub
- Contact Us
- Events
- Home
- Past Events
- Home Page
- Membership
- ACTA Staff
- Funding and Support
- Why ACTA formed
- What is a Clinical Trials Network?
- Stakeholders
- Activity plan
- ACTA International Clinical Trial Conference 2019 Videos
- ACTA Summit 2020 Registration Terms and Conditions
- Australian Clinical Trials Alliance Ltd Notice of Annual General Meeting
- ACTA Summit Program
- Types of Clinical Trial Networks (CTNs)
- ACTA STInG Data and Safety Monitoring Board Mentoring Program